Earners of this credential can recognize and define sequencing technologies and experimental models that have revolutionized the design of genomic-based therapies for cancer. Earners are able to differentiate next generation sequencing (NGS) approaches by research application, compare the advantages and limitations of cell-based cancer models, and distinguish between mouse models used in cancer research.

• Type Learning
• Level Foundational
• Time Hours